RE-BVS – Piemonte Repository

Sfoglia per AUTORE
KHAN M
Collezione AOU Città della Salute di Torino

Items : 5

Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago. in World journal of emergency surgery : WJES / World J Emerg Surg. 2024 Apr 16;19(1):14. doi: 10.1186/s13017-024-00543-w.

2024
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Agnoletti V; Catena F; Baiocchi GL; Bravi F; Vallicelli C; Coccolini F; Sartelli M; Banchini F; Capelli P; Reames S; Cairl N; Biffl WL; Truong HP; Schaffer K; Curtiss W; McClure A; Austin TR; Hyman TS; Quick JA; Hemmila M; Napolitano LM; Sangji NF; Armento I; Egodage T; Coffua LS; Echeverria-Rosario K; Ratnasekera A; Seng SS; Bardes JM; et alii...

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. in EClinicalMedicine / EClinicalMedicine. 2023 Nov 15;65:102307. doi: 10.1016/j.eclinm.2023.102307. eCollection 2023 Nov.

2023
AOU Città della Salute di Torino
AOU Novara

Claus R; Biderman B; Antic D; Angelopoulou M; Zuchnicka J; Yassin M; Yañez L; Yagci M; Xu Z; Wasik-Szczepanek E; Walewska R; Vukovic V; Vrachiolias G; von Tresckow J; Vitale C; Visentin A; Vassilakopoulos T; Tomic K; Tse E; Spacek M; Tadmor T; Abdelrahman Soliman DS; Smirnova S; Simkovic M; Shen Y; Schiwitza A; Schipani M; Daniel de Deus Santos M; Ruchlemer R; et alii...

Current status of global research on pericardial diseases: a bibliometric analysis of the top 100 from Web of Science. in Archives of medical sciences. Atherosclerotic diseases / Arch Med Sci Atheroscler Dis. 2023 Jul 27;8:e60-e70. doi: 10.5114/amsad/169506. eCollection 2023.

2023
AOU Città della Salute di Torino

Klein A; Jellis C; Kwon D; Xu B; Imazio M; Bajaj NS; Lavie CJ; Bansal A; Khan MS; Gupta K; Eken HN; Jain V; Aronow WS;

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial. in Annals of hematology / Ann Hematol. 2018 Sep;97(9):1591-1600. doi: 10.1007/s00277-018-3365-y. Epub 2018 May 27.

2018
AOU Città della Salute di Torino

Bensasson C; Guglielmelli P; Sivgin S; Devos T; Callum J; Egyed M; Palandri F; Benevolo G; Saydam G; Griesshammer M; Khan M; Ronco JP; Passamonti F; Griesshammer M; Saydam G; Palandri F; Benevolo G; Egyed M; Callum J; Devos T; Sivgin S; Guglielmelli P; Bensasson C; Khan M; Ronco JP; Passamonti F;

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study. in The Lancet. Oncology / Lancet Oncol. 2017 Jan;18(1):88-99. doi: 10.1016/S1470-2045(16)30558-7. Epub 2016 Dec 2.

2017
AOU Città della Salute di Torino

Bensasson C; Sivgin S; Vannucchi AM; Callum J; Devos T; Egyed M; Benevolo G; Palandri F; Griesshammer M; Passamonti F; Khan M; Mounedji N; Saydam G;